The boom of Viagra initially ignited significant expansion in the medicinal sector, generating a image of easy gains. However, funding in companies solely reliant on flagship drugs like Sildenafil presents significant https://emilydqqz577703.blog5star.com/41487954/the-blue-pill-and-big-pharma-a-risky-play